SG10201811119XA - Detection of biomarkers for non-small cell lung cancer - Google Patents
Detection of biomarkers for non-small cell lung cancerInfo
- Publication number
- SG10201811119XA SG10201811119XA SG10201811119XA SG10201811119XA SG10201811119XA SG 10201811119X A SG10201811119X A SG 10201811119XA SG 10201811119X A SG10201811119X A SG 10201811119XA SG 10201811119X A SG10201811119X A SG 10201811119XA SG 10201811119X A SG10201811119X A SG 10201811119XA
- Authority
- SG
- Singapore
- Prior art keywords
- biomarkers
- detection
- lung cancer
- small cell
- cell lung
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201811119XA SG10201811119XA (en) | 2018-12-12 | 2018-12-12 | Detection of biomarkers for non-small cell lung cancer |
| PCT/SG2019/050611 WO2020122817A1 (en) | 2018-12-12 | 2019-12-12 | Detection of biomarkers for non-small cell lung cancer |
| EP19894719.4A EP3894861B1 (en) | 2018-12-12 | 2019-12-12 | Detection of biomarkers for non-small cell lung cancer |
| US17/413,474 US20220260571A1 (en) | 2018-12-12 | 2019-12-12 | Detection of biomarkers for non-small cell lung cancer |
| AU2019395619A AU2019395619A1 (en) | 2018-12-12 | 2019-12-12 | Detection of biomarkers for Non-Small Cell Lung Cancer |
| KR1020217021075A KR20210104073A (en) | 2018-12-12 | 2019-12-12 | Detection of biomarkers for non-small cell lung cancer |
| CN201980091833.4A CN113614536A (en) | 2018-12-12 | 2019-12-12 | Detection of biomarkers for non-small cell lung cancer |
| CA3123382A CA3123382A1 (en) | 2018-12-12 | 2019-12-12 | Detection of biomarkers for non-small cell lung cancer |
| JP2021534631A JP7455843B2 (en) | 2018-12-12 | 2019-12-12 | Detection of biomarkers for non-small cell lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201811119XA SG10201811119XA (en) | 2018-12-12 | 2018-12-12 | Detection of biomarkers for non-small cell lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201811119XA true SG10201811119XA (en) | 2020-07-29 |
Family
ID=71077571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201811119XA SG10201811119XA (en) | 2018-12-12 | 2018-12-12 | Detection of biomarkers for non-small cell lung cancer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220260571A1 (en) |
| EP (1) | EP3894861B1 (en) |
| JP (1) | JP7455843B2 (en) |
| KR (1) | KR20210104073A (en) |
| CN (1) | CN113614536A (en) |
| AU (1) | AU2019395619A1 (en) |
| CA (1) | CA3123382A1 (en) |
| SG (1) | SG10201811119XA (en) |
| WO (1) | WO2020122817A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240026431A (en) * | 2022-08-18 | 2024-02-28 | 주식회사 메드팩토 | Biomarker for Diagnosis, Metastasis or Prognosis Prediction of Cancer and Use Thereof |
| CN117024555B (en) * | 2023-07-18 | 2024-02-13 | 遵义医科大学珠海校区 | CircLRRFIP2-60aa and application thereof in lung squamous carcinoma treatment |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006133420A2 (en) * | 2005-06-08 | 2006-12-14 | Millennium Pharmaceuticals, Inc. | Treatment of patients with cancer therapy |
| WO2009085237A2 (en) * | 2007-12-21 | 2009-07-09 | Cell Genesys, Inc. | Methods and compositions for identifying lung cancer or a humoral immune response against lung cancer |
| KR101130842B1 (en) * | 2010-04-15 | 2012-03-29 | 한국생명공학연구원 | Protein marker Xage-1d for lung cancer and diagnosis kit for lung cancer using an antibody against the same |
| WO2012054732A2 (en) | 2010-10-20 | 2012-04-26 | Rush University Medical Center | Lung cancer tests |
| JP6505713B2 (en) * | 2013-09-05 | 2019-04-24 | デンドレオン ファーマシューティカルズ インコーポレイテッド | Humoral immune response to tumor antigens after treatment with cancer antigen-specific active immunotherapy and its relevance to improved clinical outcome |
| KR101750411B1 (en) * | 2015-07-10 | 2017-06-27 | 한국생명공학연구원 | A composition comprising antigens for detecting anti-exosomal EIF3A autoantibodies and its application for diagnosing liver cancer |
| US20190262399A1 (en) * | 2016-09-07 | 2019-08-29 | The Broad Institute, Inc. | Compositions and methods for evaluating and modulating immune responses |
| US11408887B2 (en) * | 2017-05-22 | 2022-08-09 | The National Institute for Biotechnology in the Negev Ltd. | Biomarkers for diagnosis of lung cancer |
| US20220154282A1 (en) * | 2019-03-12 | 2022-05-19 | The Broad Institute, Inc. | Detection means, compositions and methods for modulating synovial sarcoma cells |
-
2018
- 2018-12-12 SG SG10201811119XA patent/SG10201811119XA/en unknown
-
2019
- 2019-12-12 WO PCT/SG2019/050611 patent/WO2020122817A1/en unknown
- 2019-12-12 US US17/413,474 patent/US20220260571A1/en active Pending
- 2019-12-12 CA CA3123382A patent/CA3123382A1/en active Pending
- 2019-12-12 EP EP19894719.4A patent/EP3894861B1/en active Active
- 2019-12-12 JP JP2021534631A patent/JP7455843B2/en active Active
- 2019-12-12 AU AU2019395619A patent/AU2019395619A1/en active Pending
- 2019-12-12 KR KR1020217021075A patent/KR20210104073A/en not_active Application Discontinuation
- 2019-12-12 CN CN201980091833.4A patent/CN113614536A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7455843B2 (en) | 2024-03-26 |
| CA3123382A1 (en) | 2020-06-18 |
| KR20210104073A (en) | 2021-08-24 |
| AU2019395619A1 (en) | 2021-07-15 |
| EP3894861A4 (en) | 2022-09-28 |
| CN113614536A (en) | 2021-11-05 |
| US20220260571A1 (en) | 2022-08-18 |
| EP3894861B1 (en) | 2024-07-10 |
| WO2020122817A1 (en) | 2020-06-18 |
| EP3894861A1 (en) | 2021-10-20 |
| JP2022513928A (en) | 2022-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1246828A1 (en) | Biomarker panel for the detection of cancer | |
| EP3443119B8 (en) | Methods for lung cancer detection | |
| EP3403093A4 (en) | Plasma autoantibody biomarkers for diagnosis of lung cancer | |
| EP3443066A4 (en) | Methods for early detection of cancer | |
| EP3458612A4 (en) | Methods for subtyping of lung adenocarcinoma | |
| GB201808476D0 (en) | Biomarkers for colorectal cancer | |
| IL253710A0 (en) | Biomarkers for pancreatic cancer and kits and methods for detecting same | |
| EP3606507A4 (en) | Serological biomarkers for early diagnosis of lung cancer | |
| EP3647788A4 (en) | Biomarker for detecting colorectal cancer | |
| IL270717A (en) | Biomarkers for diagnosis of lung cancer | |
| IL250830A0 (en) | Early lung cancer detection by dna methylation phenotyping of sputum-derived cells | |
| HK1247242A1 (en) | Biomarker for detection of lung adenocarcinoma and use thereof | |
| SG11202112523UA (en) | Detection of colorectal cancer | |
| SG11202112522TA (en) | Detection of colorectal cancer | |
| EP3341496A4 (en) | Methods of detecting cancer recurrence | |
| EP3864165A4 (en) | Detecting cancer cell of origin | |
| EP3894861A4 (en) | Detection of biomarkers for non-small cell lung cancer | |
| EP3080299A4 (en) | Biomarkers of rapid progression in advanced non-small cell lung cancer | |
| EP3607066A4 (en) | Methods of detecting lung cancer | |
| EP3247825A4 (en) | Metabolomic based biomarkers for colon cancer detection | |
| GB201915469D0 (en) | Cancer detection methods | |
| EP3111223C0 (en) | Biomarkers for lung cancer, associated methods, and kits | |
| EP3899531A4 (en) | Method of detecting lung cancer | |
| EP4045905A4 (en) | Method of diagnosing early-stage non-small cell lung cancer | |
| EP4083627A4 (en) | Prognostic biomarker of cancer |